ANTIBODY-RESPONSES TO LIPID-A, CORE, AND O-SUGARS OF THE PSEUDOMONAS-AERUGINOSA LIPOPOLYSACCHARIDE IN CHRONICALLY INFECTED CYSTIC-FIBROSIS PATIENTS

被引:38
作者
KRONBORG, G
FOMSGAARD, A
GALANOS, C
FREUDENBERG, MA
HOIBY, N
机构
[1] RIGSHOSP, DANISH CF CTR, DK-2100 COPENHAGEN, DENMARK
[2] MAX PLANCK INST IMMUNBIOL, W-7800 FREIBURG, GERMANY
关键词
D O I
10.1128/JCM.30.7.1848-1855.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Enzyme-linked immunosorbent assays were developed separately for the three main parts of the Pseudomonas aeruginosa lipopolysaccharide (LPS) molecule, namely, lipid A, core, and O polysaccharide. Anti-lipid A, anticore, and anti-O polysaccharide antibodies were measured in serum samples from 12 patients with cystic fibrosis (CF) in a longitudinal study covering the period before P. aeruginosa infection was established through at least 5 years of chronic infection. The serum antibody response to all parts of the P. aeruginosa LPS molecule increased during the course of chronic infection. The increase in anti-lipid A antibodies was specific for P. aeruginosa lipid A, since no increase in anti-Escherichia coli lipid A antibodies was seen. Immunoglobulin G, A, and M (IgG, IgA and IgM) antibodies were all involved in the specific systemic response to P. aeruginosa lipid A, core, and the O polysaccharides. IgG and IgA levels in particular increased during the course of infection and were significantly higher than the antibody increase seen with age in a healthy control group. The local immune response in the lungs was investigated by measuring IgG, IgA, and IgM antibodies to the separate parts of the P. aeruginosa LPS molecule in sputum samples from 18 CF patients with at least a 5-year history of chronic P. aeruginosa infection. Antibodies detected in sputum were mainly anti-lipid A and anti-O polysaccharide antibodies of the IgG and IgA isotypes. Very high IgA anti-lipid A titers were detected in sputum samples from some CF patients.
引用
收藏
页码:1848 / 1855
页数:8
相关论文
共 43 条
[31]   PREVALENCE AND PERSISTENCE OF POLYAGGLUTINABLE PSEUDOMONAS-AERUGINOSA IN ISOLATES FROM CYSTIC-FIBROSIS PATIENTS [J].
OJENIYI, B ;
HOIBY, N ;
ROSDAHL, VT .
APMIS, 1991, 99 (02) :187-195
[32]   DIAGNOSIS OF CHRONIC PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
PEDERSEN, SS ;
ESPERSEN, F ;
HOIBY, N .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (10) :1830-1836
[33]  
PIER GB, 1981, J IMMUNOL, V127, P184
[34]   CHARACTERIZATION OF THE HUMAN IMMUNE-RESPONSE TO A POLYSACCHARIDE VACCINE FROM PSEUDOMONAS-AERUGINOSA [J].
PIER, GB ;
THOMAS, DM .
JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (02) :206-213
[35]   POLYAGGLUTINATING AND NONTYPABLE STRAINS OF PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS [J].
PITT, TL ;
MACDOUGALL, J ;
PENKETH, ARL ;
COOKE, EM .
JOURNAL OF MEDICAL MICROBIOLOGY, 1986, 21 (02) :179-186
[36]   STRUCTURE OF THE CORE OLIGOSACCHARIDE FROM THE LIPOPOLYSACCHARIDE OF PSEUDOMONAS-AERUGINOSA PAC1R AND ITS DEFECTIVE-MUTANTS [J].
ROWE, PSN ;
MEADOW, PM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1983, 132 (02) :329-337
[37]  
RYAN JL, 1985, SEPTIC SHOCK, P13
[38]  
SCHIOTZ PO, 1981, ACTA PATH MICRO IM C, P1
[39]  
Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030
[40]  
WOOD RE, 1976, AM REV RESPIR DIS, V113, P833